<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Inhaled anticholinergics and short‐acting beta2‐agonists versus short‐acting beta2‐agonists alone for children with acute asthma in hospital - Vézina, K - 2014 | Cochrane Library</title> <meta content="Inhaled anticholinergics and short‐acting beta2‐agonists versus short‐acting beta2‐agonists alone for children with acute asthma in hospital - Vézina, K - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010283.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Inhaled anticholinergics and short‐acting beta2‐agonists versus short‐acting beta2‐agonists alone for children with acute asthma in hospital - Vézina, K - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010283.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010283.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Inhaled anticholinergics and short‐acting beta&lt;sub&gt;2&lt;/sub&gt;‐agonists versus short‐acting beta2‐agonists alone for children with acute asthma in hospital" name="citation_title"/> <meta content="Kevin Vézina" name="citation_author"/> <meta content="CHU Sainte‐Justine" name="citation_author_institution"/> <meta content="Bhupendrasinh F Chauhan" name="citation_author"/> <meta content="Research Centre, CHU Sainte‐Justine" name="citation_author_institution"/> <meta content="Francine M Ducharme" name="citation_author"/> <meta content="francine.m.ducharme@umontreal.ca" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD010283.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/07/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010283.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010283.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010283.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease; Administration, Inhalation; Adrenergic beta‐2 Receptor Agonists [*administration &amp; dosage]; Anti‐Asthmatic Agents [*administration &amp; dosage]; Asthma [*drug therapy]; Cholinergic Antagonists [*administration &amp; dosage]; Drug Administration Schedule; Drug Therapy, Combination; Hospitalization; Ipratropium [administration &amp; dosage]; Nebulizers and Vaporizers; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010283.pub2&amp;doi=10.1002/14651858.CD010283.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="cdmLYOAV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010283\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010283\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010283.pub2",title:"Inhaled anticholinergics and short\\u2010acting beta\u003csub\u003e2\u003c/sub\u003e\\u2010agonists versus short\\u2010acting beta2\\u2010agonists alone for children with acute asthma in hospital",firstPublishedDate:"Jul 31, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Airways Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=cdmLYOAV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010283.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010283.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010283.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010283.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010283.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010283.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010283.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010283.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010283.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010283.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4616 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010283.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-sec-0089"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-sec-0053"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-sec-0083"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/appendices#CD010283-sec-0094"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/table_n/CD010283StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/table_n/CD010283StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Inhaled anticholinergics and short‐acting beta<sub>2</sub>‐agonists versus short‐acting beta2‐agonists alone for children with acute asthma in hospital </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/information#CD010283-cr-0002">Kevin Vézina</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/information#CD010283-cr-0003">Bhupendrasinh F Chauhan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010283.pub2/information#CD010283-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Francine M Ducharme</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/information/en#CD010283-sec-0103">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 July 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010283.pub2">https://doi.org/10.1002/14651858.CD010283.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010283-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010283-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010283-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010283-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010283-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010283-abs-0001" lang="en"> <section id="CD010283-sec-0001"> <h3 class="title" id="CD010283-sec-0001">Background</h3> <p>Inhaled anticholinergics given in addition to β<sub>2</sub>‐agonists are effective in reducing hospital admissions in children presenting to the emergency department with a moderate to severe asthma exacerbation. It seems logical to assume a similar beneficial effect in children hospitalised for an acute asthma exacerbation. </p> </section> <section id="CD010283-sec-0002"> <h3 class="title" id="CD010283-sec-0002">Objectives</h3> <p>To assess the efficacy and safety of anticholinergics added to β<sub>2</sub>‐agonists as inhaled or nebulised therapy in children hospitalised for an acute asthma exacerbation. To investigate the characteristics of patients or therapy, if any, that would influence the magnitude of response attributable to the addition of anticholinergics. </p> </section> <section id="CD010283-sec-0003"> <h3 class="title" id="CD010283-sec-0003">Search methods</h3> <p>We identified trials from the Cochrane Airways Group Specialised Register of trials (CAGR), which is derived through systematic searches of bibliographic databases including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, AMED and PsycINFO and through handsearching of respiratory journals and meeting abstracts. The search is current to November 2013. </p> </section> <section id="CD010283-sec-0004"> <h3 class="title" id="CD010283-sec-0004">Selection criteria</h3> <p>Randomised trials comparing the combination of inhaled or nebulised anticholinergics and short‐acting β<sub>2</sub>‐agonists versus short‐acting β<sub>2</sub>‐agonists alone in children one to 18 years of age hospitalised for an acute asthma exacerbation were eligible. </p> </section> <section id="CD010283-sec-0005"> <h3 class="title" id="CD010283-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed the methodological quality of trials and extracted data; disagreement was resolved by consensus or with the input of a third review author, when needed. Primary outcomes were duration of hospital stay and serious adverse events. Secondary outcomes included admission and duration of stay in the intensive care unit (ICU), ventilation assistance, time to short‐acting β<sub>2</sub>‐agonists spaced at four hours or longer, supplemental asthma therapy, duration of supplemental oxygen, change from baseline in asthma severity, relapse after discharge, adverse health effects and withdrawals. </p> </section> <section id="CD010283-sec-0006"> <h3 class="title" id="CD010283-sec-0006">Main results</h3> <p>Seven randomised trials were included, four of which reported usable data on 472 children with asthma one to 18 years of age who were admitted to paediatric wards. No trials included patients admitted to the ICU. The anticholinergic used, ipratropium bromide 250 μg, was given every one to eight hours over a period from four hours to the entire length of the hospital stay. Two of four trials (50%) contributing data were deemed of high methodological quality. The addition of anticholinergics to β<sub>2</sub>‐agonists showed no evidence of effect on the duration of hospital admission (mean difference (MD) ‐0.28 hours, 95% confidence interval (CI) ‐5.07 to 4.52, 3 studies, 327 participants, moderate quality evidence) and no serious or non‐serious adverse events were reported in any included trials. As a result of the similarity of trials, we could not explore the influence of age, admission site, intensity of anticholinergic treatment and co‐interventions on primary outcomes. No statistically significant group difference was noted in other secondary outcomes, including the need for supplemental asthma therapy, time to short‐acting β<sub>2</sub>‐agonists spaced at four hours or longer, asthma clinical scores, lung function and overall withdrawals for any reason. </p> </section> <section id="CD010283-sec-0007"> <h3 class="title" id="CD010283-sec-0007">Authors' conclusions</h3> <p>In children hospitalised for an acute asthma exacerbation, no evidence of benefit for length of hospital stay and other markers of response to therapy was noted when nebulised anticholinergics were added to short‐acting β<sub>2</sub>‐agonists. No adverse health effects were reported, yet the small number of trials combined with inadequate reporting prevent firm reassurance regarding the safety of anticholinergics. In the absence of trials conducted in ICUs, no conclusion can be drawn regarding children with impending respiratory failure. These findings support current national and international recommendations indicating that healthcare practitioners should refrain from using anticholinergics in children hospitalised for acute asthma. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010283-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010283-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010283-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010283-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010283-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010283-abs-0006">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010283-abs-0004" lang="en"> <h3>Are inhaled anticholinergics added to β2‐agonists beneficial in children hospitalised with acute asthma? </h3> <p><b>Background:</b> Anticholinergics (e.g. ipratropium bromide, atropine sulfate) are inhaled drugs. They relax the airway muscles and decrease secretions. Anticholinergics are sometimes used in addition to beta<sub>2</sub>‐agonists (such as salbutamol and terbutaline), which are potent drugs given to relax smooth muscles in the airways in children with acute asthma. We do not know whether the addition of inhaled anticholinergics to beta<sub>2</sub>‐agonists is beneficial for children hospitalised with acute asthma. </p> <p><b>Review question:</b> We wished to examine the efficacy and safety of inhaled or nebulised (mist inhaled into the lungs) anticholinergics added to beta<sub>2</sub>‐agonists compared with beta<sub>2</sub>‐agonists alone in children one to 18 years of age hospitalised for an acute asthma exacerbation. </p> <p><b>Study characteristics:</b> In reviewing evidence available until November 2013, we found seven eligible studies of children hospitalised with acute asthma; four of these studies (472 children one to 18 years of age) contributed data to the review. Four studies compared the combination of anticholinergics (ipratropium bromide) and beta<sub>2</sub>‐agonists versus the same dose of beta<sub>2</sub>‐agonists alone. Included studies enrolled both girls and boys, with a gender ratio ranging from 59% to 73% males. </p> <p><b>Results:</b> No additional benefit was noted by adding anticholinergics to β<sub>2</sub>‐agonists in terms of duration of hospital stay in patients compared to those who received beta<sub>2</sub>‐agonists alone. Two of four trials (50%) contributing data were deemed of high methodological quality. No trial reported information on serious adverse events. No statistically significant group difference was noted in other markers of response to therapy, that is, the need for supplemental asthma therapy, time to short‐acting beta<sub>2</sub>‐agonists spaced at four hours or longer, asthma clinical scores, lung function and overall withdrawals for any reason. </p> <p><b>Conclusion:</b> No apparent benefit is derived from adding anticholinergics to beta<sub>2</sub>‐agonists in children hospitalised for an acute asthma exacerbation, that is, beyond initial treatment in the emergency department. No adverse health effects were reported, yet the small number of trials combined with inadequate reporting prevents firm reassurance regarding the safety of anticholinergics. In the absence of trials conducted in the intensive care unit (ICU), no conclusion can be drawn regarding children with very severe exacerbations who are admitted to the ICU. Our findings support the ongoing recommendations provided by national and international guidelines. </p> <p><b>Quality of the results:</b> This review is based on a small number of identified trials conducted in children with acute asthma. All trials contributing to the primary outcome are of high methodological quality, but they are few. As the addition of new trials may change the conclusion, the quality of evidence was downgraded from high to moderate. Additional and larger trials are needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010283-sec-0089" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010283-sec-0089"></div> <h3 class="title" id="CD010283-sec-0090">Implications for practice</h3> <section id="CD010283-sec-0090"> <p>Among children hospitalised for an acute asthma exacerbation, no evidence suggests that nebulised anticholinergics added to β<sub>2</sub>‐agonists are effective in reducing length of hospital stay, need for supplemental asthma therapy or time to short‐acting β<sub>2</sub>‐agonists spaced at four hours or longer, or that this combination improves clinical scores compared with those of β<sub>2</sub>‐agonists alone. Data are insufficient to reveal whether specific subgroups of patients are more likely to benefit, or if certain characteristics of therapy may influence the magnitude of response attributable to the addition of anticholinergics. </p> <p>Because of the absence of identified studies conducted in the ICU, no evidence elucidates the possible role of anticholinergics in children with impending respiratory failure. </p> <p><i>No adverse health effects were reported; yet the small number of trials combined with inadequate reporting prevented firm reassurance regarding the safety of anticholinergics.</i> </p> <p>Results support the recommendation of current guidelines that anticholinergics are not indicated in children hospitalised for an acute asthma exacerbation, beyond initial treatment in the emergency department. </p> </section> <h3 class="title" id="CD010283-sec-0091">Implications for research</h3> <section id="CD010283-sec-0091"> <p>Additional efficacy studies are needed to increase the precision of summary estimates and, urgently, to explore the efficacy of ipratropium bromide in children with impending respiratory failure. </p> <p>Trials of high methodological quality with adequate documentation of adverse health effects associated with anticholinergics are needed to provide a fair comparison of the safety of these treatment options. </p> <p>Future trials should aim to incorporate the following design characteristics.</p> <p> <ol id="CD010283-list-0005"> <li> <p>Inclusion of double‐blinding and adequate randomisation with details provided on allocation concealment and complete reporting of withdrawals and dropouts on intention‐to‐treat analysis. </p> </li> <li> <p>Comparison of different intensities of anticholinergic therapy.</p> </li> <li> <p>Subgroup data on patients stratified by age group (preschool children vs school‐aged children) and severity of asthma on admission (mild, moderate or severe). </p> </li> <li> <p>Continuous data provided as means with standard deviations.</p> </li> <li> <p>Report of changes from baseline (at the time of randomisation) in asthma severity.</p> </li> <li> <p>Systematic documentation of serious, overall and specific adverse health effects.</p> </li> <li> <p>Systematic documentation of reasons for withdrawals.</p> </li> </ol> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010283-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010283-sec-0022"></div> <div class="table" id="CD010283-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Combination of anticholinergics + beta2‐agonists versus beta2‐agonists alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Combination of AC + beta<sub>2</sub>‐agonists versus beta<sub>2</sub>‐agonists alone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: children hospitalised with an acute asthma exacerbation</b> <br/> <b>Settings:</b> hospitalised<br/> <b>Intervention:</b> combination of anticholinergic + beta<sub>2</sub>‐agonists<br/> <b>Comparison:</b> beta<sub>2</sub>‐agonists alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Beta<sub>2</sub>‐agonistsalone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Combination of AC + beta<sub>2</sub>‐agonists</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of the hospital stay (hours)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of the hospital stay (hours) in the control groups was<br/> 44 hours </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in duration of hospital stay (hours) was 0.28 hours in the intervention groups </p> <p>Mean 43.8 (39 to 49) hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐0.28 hours</b> <br/> (‐5.07 to 4.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>327<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to regular dose of short‐acting beta<sub>2</sub>‐agonists (hours)<sup>2</sup> </b> </p> <p><b>Follow‐up: 4 hours or longer</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to regular short‐acting beta<sub>2</sub>‐agonists in the control groups was 33 hours </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in time to regular short‐acting beta<sub>2</sub>‐agonists in the intervention groups was 2.17 hours </p> <p>Mean 31 (26 to 36) hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐2.17 hours</b> <br/> (‐7.01 to 2.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>269<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asthma clinical scores</b> </p> <p><b>Follow‐up: 8 to 36 hours after initial treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.02 SMD</b> (‐0.34 to 0.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>117<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Scores were measured on different scales.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Admission to the intensive care unit</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>210<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single trial reported admission to the intensive care unit. No events were reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall withdrawals</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 100</b> <br/> (4 to 15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.59</b> <br/> (0.27 to 1.30) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>294<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse health events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>290<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adverse events were reported in either trial</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the mean control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded because of wide confidence intervals. </p> <p><sup>2</sup>This is the time at which emergency dosing with the trial intervention was replaced with regular 4‐hourly treatment with short‐acting beta<sub>2</sub>‐agonists. </p> <p><sup>3</sup>No events were reported in either arm of the studies. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010283-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010283-sec-0023"></div> <section id="CD010283-sec-0024"> <h3 class="title" id="CD010283-sec-0024">Description of the condition</h3> <p>Asthma is a chronic inflammatory disorder of the airways that is associated with airway hyperresponsiveness (<a href="./references#CD010283-bbs2-0141" title="Ortiz‐AlvarezO , MikrogianakisA , Canadian Paediatric Society, Acute Care Committee. Managing the paediatric patient with an acute asthma exacerbation. Paediatr Child Health2012;17(5):251‐5. ">Ortiz‐Alvarez 2012</a>). Globally the prevalence of severe asthma symptoms, defined as four or more attacks of wheeze or one or more night per week of sleep disturbance from wheeze or wheeze affecting speech in the past 12 months ranged from 0% to 20% in children (<a href="./references#CD010283-bbs2-0128" title="AsherMI . Recent perspectives on global epidemiology of asthma in childhood. Allergology and Immunolopathology2010;38(2):83‐7. ">Asher 2010</a>; <a href="./references#CD010283-bbs2-0137" title="LaiCKW , BeasleyR , CraneJ , FoliakiS , ShahJ , WeilandS , the ISAAC Phase Three Study Group. Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax2009;64:476‐83. ">Lai 2009</a>). Asthma exacerbation is defined as an acute or subacute worsening of symptoms and lung function from the individual's usual status or, in some cases, the initial presentation of asthma (<a href="./references#CD010283-bbs2-0132" title="Global Initiative forAsthma . From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf (accessed 8 January 2014). ">GINA 2014</a>). One of the main goals in the management of acute asthma exacerbations in children is to achieve a rapid reversal of airflow obstruction (<a href="./references#CD010283-bbs2-0140" title="National Asthma education and Prevention Program. NAEPP Expert Panel Report Guidelines for the Diagnosis and Management of Asthma. http://www.nhlbi.nih.gov/guidelines/asthma/ (accessed 8 January 2014). ">NAEPP 2011</a>). This is achieved by using inhaled or nebulised short‐acting β<sub>2</sub>‐agonists (<a href="./references#CD010283-bbs2-0129" title="CamargoCAJr , EmondSD , BouletL , GibsonPG , KolbeJ , WagnerCW , et al. Emergency department‐asthma plan. Developed at: Asthma Education in the Adult Emergency Department: A Multidisciplinary Consensus Conference. New York, 2001. ">Camargo 2003</a>; <a href="./references#CD010283-bbs2-0136" title="KarpelJP , AldrichTK , PrezantDJ , GuguchevK , Gaitan‐SalasA , PathipartiR . Emergency treatment of acute asthma with albuterol metered‐dose inhaler plus holding chamber: how often should treatments be administered?. Chest1997;112(2):348‐56. ">Karpel 1997</a>), which are the most effective bronchodilators because of their rapid onset of action and the magnitude of bronchodilation that they achieve (<a href="./references#CD010283-bbs2-0147" title="SearsMR . Clinical application of beta‐agonists. Practical Allergy and Immunology1992;7:98‐100. ">Sears 1992</a>; <a href="./references#CD010283-bbs2-0150" title="SvedmyrN . A beta2‐adrenergic agonist for use in asthma pharmacology, pharmacokinetics, clinical efﬁcacy and adverse effects. Pharmacotherapy1985;5:109‐26. ">Svedmyr 1985</a>). Systemic corticosteroids should be added early in the course of treatment for patients who have moderate or severe exacerbations or for children who fail to respond promptly and completely to bronchodilators (<a href="./references#CD010283-bbs2-0143" title="RachelefskyG . Treating exacerbations of asthma in children: the role of systemic corticosteroids. Pediatrics2003;112(2):382‐97. ">Rechelefsky 2003</a>; <a href="./references#CD010283-bbs2-0146" title="RoweBH , EdmondsML , SpoonerCH , DinerB , CamargoCAJr . Corticosteroid therapy for acute asthma. Respiratory Medicine2004;98(4):275‐84. ">Rowe 2004</a>). </p> </section> <section id="CD010283-sec-0025"> <h3 class="title" id="CD010283-sec-0025">Description of the intervention</h3> <p>Anticholinergic agents, such as ipratropium bromide and atropine sulfate, have a slower onset of action and a weaker bronchodilating effect but may specifically relieve cholinergic bronchomotor tone and decrease mucosal edema and secretions (<a href="./references#CD010283-bbs2-0130" title="ChapmanK . An international perspective on anticholinergic therapy. American Journal of Medicine1996;100:2‐4S. ">Chapman 1996</a>; <a href="./references#CD010283-bbs2-0134" title="GrossNJ . Ipratropium bromide. New England Journal of Medicine1988;8:486–94. ">Gross 1988</a>; <a href="./references#CD010283-bbs2-0148" title="SilvermanM . The role of anticholinergic antimuscarinic bronchodilator therapy in children. Lung1990;168:304‐9. ">Silverman 1990</a>). Thus, with their slower onset but prolonged duration of action, anticholinergics (AC) can work as complementary therapy to β<sub>2</sub>‐agonists, thereby enhancing bronchodilation. </p> <p>Several trials have explored the role of ipratropium bromide in the emergency department setting. One systematic review of randomised controlled trials (RCTs) concluded that multiple doses of inhaled anticholinergic agents added to β<sub>2</sub>‐agonist therapy in the initial treatment of children with acute asthma exacerbations were safe and efficacious, with most of the effect observed in those with severe asthma exacerbations and no apparent benefit noted in children presenting with mild to moderate asthma exacerbations (<a href="./references#CD010283-bbs2-0142" title="PlotnickL , DucharmeF . Combined inhaled anticholinergics and beta2‐agonists for initial treatment of acute asthma in children. Cochrane Database of Systematic Reviews2000, Issue 3. [DOI: 10.1002/14651858.CD000060] ">Plotnick 2000</a>). An updated Cochrane review suggests that the benefit extends to children with moderate and severe exacerbations (<a href="./references#CD010283-bbs2-0133" title="GriffithsB , DucharmeFM . Combined inhaled anticholinergics and short‐acting beta2‐agonists for initial treatment of acute asthma in children. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD000060.pub2] ">Griffiths 2013</a>). Moreover, multiple doses of inhaled anticholinergic agents added to β<sub>2</sub>‐agonists have been shown to be cost‐effective (<a href="./references#CD010283-bbs2-0139" title="LordJ , DucharmeFM , StampRL , LittlejohnsP , ChurchillR . Cost effectiveness analysis of inhaled anticholinergics for acute childhood and adolescent asthma. BMJ1999;319:1470‐1. ">Lord 1999</a>). </p> </section> <section id="CD010283-sec-0026"> <h3 class="title" id="CD010283-sec-0026">How the intervention might work</h3> <p>To our knowledge, two trials have assessed the efficacy of ipratropium bromide added to β<sub>2</sub>‐agonists after the emergency department treatment period, that is, in children hospitalised for an acute asthma exacerbation (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>). Both trials independently demonstrated no benefit conferred by the addition of anticholinergics. Consequently, national and international asthma guidelines currently recommend that inhaled anticholinergics should not be used in hospitalised children with acute asthma (<a href="./references#CD010283-bbs2-0132" title="Global Initiative forAsthma . From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf (accessed 8 January 2014). ">GINA 2014</a>; <a href="./references#CD010283-bbs2-0140" title="National Asthma education and Prevention Program. NAEPP Expert Panel Report Guidelines for the Diagnosis and Management of Asthma. http://www.nhlbi.nih.gov/guidelines/asthma/ (accessed 8 January 2014). ">NAEPP 2011</a>). Yet, in several institutions, anticholinergics are used for a specified period of time after children are admitted, particularly, but not only, those admitted to the intensive care unit (ICU). </p> </section> <section id="CD010283-sec-0027"> <h3 class="title" id="CD010283-sec-0027">Why it is important to do this review</h3> <p>The difference in practice between institutions, termed practice variation, underlines a gap between recommended and observed care, or a care gap. In the absence of an identified systematic review, we believe that a Cochrane review would clarify the evidence accumulated to date regarding the role of anticholinergics in the treatment of children hospitalised for an acute asthma exacerbation. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010283-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010283-sec-0028"></div> <p>To assess the efficacy and safety of anticholinergics added to β<sub>2</sub>‐agonists as inhaled or nebulised therapy in children hospitalised for an acute asthma exacerbation. To investigate the characteristics of patients or therapy, if any, that would influence the magnitude of response attributable to the addition of anticholinergics. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010283-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010283-sec-0029"></div> <section id="CD010283-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010283-sec-0031"> <h4 class="title">Types of studies</h4> <p>We included all RCTs.</p> </section> <section id="CD010283-sec-0032"> <h4 class="title">Types of participants</h4> <p>We included children one to 18 years of age who were hospitalised for an acute asthma exacerbation. </p> </section> <section id="CD010283-sec-0033"> <h4 class="title">Types of interventions</h4> <p>Intervention: nebulised or inhaled anticholinergics with short‐acting β<sub>2</sub>‐agonists. </p> <p>Comparison: nebulised or inhaled short‐acting β<sub>2</sub>‐agonists alone. </p> <p>Co‐interventions: Systemic corticosteroids were anticipated and permitted, provided they were similar in the two groups.   </p> </section> <section id="CD010283-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD010283-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010283-list-0001"> <li> <p>Duration of hospital stay.</p> </li> <li> <p>Serious adverse events.</p> </li> </ol> </p> </section> <section id="CD010283-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010283-list-0002"> <li> <p>Duration of stay in the ICU (for those admitted to the ICU).</p> </li> <li> <p>Admission to the ICU (for those admitted on the wards).</p> </li> <li> <p>Ventilation assistance.</p> </li> <li> <p>Need for supplemental asthma therapy (e.g. aminophylline).</p> </li> <li> <p>Duration of need for supplemental oxygen.</p> </li> <li> <p>Time to short‐acting β<sub>2</sub>‐agonists spaced at four hours or longer. </p> </li> <li> <p>Change from baseline in asthma severity measured as lung function, symptoms or clinical scores. </p> </li> <li> <p>Relapse within 72 hours of discharge from hospital.</p> </li> <li> <p>Adverse health events.</p> </li> <li> <p>Withdrawals, namely, overall withdrawals, withdrawals due to poor control of symptoms or deterioration and withdrawals due to adverse effects. </p> </li> </ol> </p> </section> </section> </section> <section id="CD010283-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010283-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We identified trials from the Cochrane Airways Group Specialised Register of trials (CAGR), which is derived through systematic searches of bibliographic databases including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, AMED and PsycINFO, and through handsearching of respiratory journals and meeting abstracts (see <a href="./appendices#CD010283-sec-0095">Appendix 1</a> for further details). We searched all records in the CAGR coded as "asthma," using the strategy provided in <a href="./appendices#CD010283-sec-0101">Appendix 2</a>. The literature search covered all years from inception until November 2013. </p> <p>No restriction on type or language of publication was applied.</p> </section> <section id="CD010283-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of all identified RCTs to identify potentially relevant citations. We checked the websites of international headquarters of pharmaceutical companies producing anticholinergics for reports of relevant completed trials. We also explored the ClinicalTrials.gov website for relevant clinical trials. </p> </section> </section> <section id="CD010283-sec-0040"> <h3 class="title" id="CD010283-sec-0040">Data collection and analysis</h3> <p>Two review authors (KV and BFC) independently extracted data, and disagreement was resolved by consensus or through the input of a third review author (FMD). When necessary, we contacted authors of included studies to request missing data. </p> <section id="CD010283-sec-0041"> <h4 class="title">Selection of studies</h4> <p>One review author (KV) independently reviewed each abstract and annotated each as (1) RCT; (2) clearly not an RCT; or (3) unclear. The full‐text publications of citations identified as included RCTs or unclear were reviewed by two review authors independently. </p> </section> <section id="CD010283-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (KV and BFC) independently extracted data, and disagreement was resolved by consensus or with the input of a third review author (FMD), when needed. </p> </section> <section id="CD010283-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the methodological quality of included trials by using the 'Risk of bias' tool of The Cochrane Collaboration, which is based on: </p> <p> <ol id="CD010283-list-0003"> <li> <p>random sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding of participants and personnel;</p> </li> <li> <p>blinding of outcome assessment;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting; and</p> </li> <li> <p>other bias.</p> </li> </ol> </p> <p>Quality assessment was performed independently by two review authors. We resolved disagreement by consensus or with the input of a third review author. The study was deemed to have high methodological quality if reported randomisation procedures and blinding were adequate and there was a low and balanced group attrition, supporting a low risk of bias. </p> </section> <section id="CD010283-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated treatment effects for dichotomous variables as risk ratio (RR) or risk difference (RD), or both, with 95% confidence intervals (CIs). We assumed equivalence if the RR estimate and its 95% CI fell between 0.9 and 1.1. For continuous outcomes, such as lung function tests, we calculated pooled statistics as mean difference (MD) or standardised mean difference (SMD) with 95% CI. </p> </section> <section id="CD010283-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the participant. If a trial had more than one intervention or control group, we considered additional comparisons, when appropriate. </p> </section> <section id="CD010283-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>When possible, we contacted investigators or study sponsors to obtain missing numerical outcome data or data in the required format to allow aggregation in the review. We did not impute missing data. </p> </section> <section id="CD010283-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>Homogeneity between included studies for which results were pooled will be tested with the DerSimonian and Laird method, and I<sup>2</sup> &gt; 40% was to be used as the cutoff level for significance. In cases of statistically significant heterogeneity, a random‐effects model was applied to the summary estimates. Unless specified otherwise, the fixed‐effect model was used. </p> </section> <section id="CD010283-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>If missing or incomplete outcome data were identified, we attempted to contact study authors to obtain the missing data. </p> </section> <section id="CD010283-sec-0049"> <h4 class="title">Data synthesis</h4> <p>Summary estimates were reported with their 95% CIs. We performed meta‐analysis using <a href="./references#CD010283-bbs2-0144" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 5.2</a>. </p> </section> <section id="CD010283-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analyses were planned to explore possible reasons for heterogeneity of study results for primary outcomes. A priori defined subgroups were based on: </p> <p> <ol id="CD010283-list-0004"> <li> <p>age (preschool children vs school‐aged children);</p> </li> <li> <p>admission site (hospital ward vs intensive care unit);</p> </li> <li> <p>intensity of anticholinergic treatment; and</p> </li> <li> <p>co‐intervention with systemic corticosteroids (yes or no).</p> </li> </ol> </p> </section> <section id="CD010283-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>For the primary outcomes, we planned to perform sensitivity analyses for publication status by removing the unpublished data, and for methodological quality by removing trials that did not meet the following criteria: random sequence generation, double‐blinding and low and balanced attrition in both groups. </p> <section id="CD010283-sec-0052"> <h5 class="title">Summary of findings table</h5> <p>We created a 'Summary of findings' table using the primary and secondary outcomes. We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of a body of evidence as it relates to the studies contributing data to the meta‐analyses for prespecified outcomes. We used methods and recommendations as described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010283-bbs2-0135" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated September 2011]. The Cochrane Collaboration. www.cochrane‐handbook.org, 2011. ">Higgins 2011</a>) and GRADE pro software. We justified all decisions to downgrade or upgrade the quality of studies by using footnotes and made comments to aid readers' understanding of the review, when necessary. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010283-sec-0053" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010283-sec-0053"></div> <section id="CD010283-sec-0054"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD010283-sec-0106" title="">Characteristics of included studies</a>; <a href="./references#CD010283-sec-0107" title="">Characteristics of excluded studies</a> and <a href="./references#CD010283-sec-0108" title="">Characteristics of ongoing studies</a> </p> <section id="CD010283-sec-0055"> <h4 class="title">Results of the search</h4> <p>The search, conducted until November 2013, yielded a total of 127 citations (<a href="#CD010283-fig-0001">Figure 1</a>). Of these, 120 citations were excluded for the following non–mutually exclusive reasons: (1) duplicate references (N = 3), (2) ongoing trials (N = 1), (3) studies not randomised trials (N = 8), (4) participants not asthmatic (N = 7), (5) participants not exclusively children (N = 38), (6) participants not hospitalised for an acute asthma exacerbation or not receiving treatment beyond initial treatment in the emergency department (N = 48), (7) intervention not a combination of anticholinergics and β<sub>2</sub>‐agonists (N = 11) and (8) control intervention not β<sub>2</sub>‐agonist alone (N = 4). </p> <div class="figure" id="CD010283-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010283-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010283-sec-0056"> <h4 class="title">Included studies</h4> <p>Seven trials met the inclusion criteria for this review. Of these, three eligible clinical trials did not contribute data to the review because reports were incomplete (<a href="./references#CD010283-bbs2-0003" title="LewDB , HerrodHG , CrawfordLV . Combination of atropine and isoetharine aerosol therapy in pediatric acute asthma. Annals of Allergy1990;64(2 Pt 2):195‐200. [] ">Lew 1990</a>; <a href="./references#CD010283-bbs2-0004" title="MirkinsonLJ , OttoliniMM . The evaluation of the use of ipratropium bromide in children hospitalized with acute asthma. Pediatric Research2000;47(4):479A. [; CN‐00401958] ">Mirkinson 2000</a>; <a href="./references#CD010283-bbs2-0005" title="OzdemirM , AkcakayaN , CamiogluY , CokugrasH . Ipratropium bromide plus nebulized ÃŸ‐2 agonist for the treatment of hospitalized children with acute asthma attack [Abstract]. Allergy and Clinical Immunology International: Journal of the World Allergy Organization2003;1(Suppl):Abstract No: P‐2‐7. [] ">Ozdemir 2003</a>). The data presented hereafter pertain to only four eligible trials, representing a total of 472 children hospitalised for an acute asthma exacerbation that contributed data to this meta‐analysis (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>; <a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>). All four trials were published in full text. We describe below the characteristics of trials that contributed data for analysis for this review. </p> <section id="CD010283-sec-0057"> <h5 class="title">Design</h5> <p>All included trials had a parallel‐group design (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>; <a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>), and the data on lung function as presented in one trial (<a href="./references#CD010283-bbs2-0003" title="LewDB , HerrodHG , CrawfordLV . Combination of atropine and isoetharine aerosol therapy in pediatric acute asthma. Annals of Allergy1990;64(2 Pt 2):195‐200. [] ">Lew 1990</a>) could not be aggregated because of its cross‐over design. </p> </section> <section id="CD010283-sec-0058"> <h5 class="title">Participants</h5> <p>All four trials involved children one to 18 years of age (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>; <a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>). The mean (or median) age of children in three studies was five years or younger (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>) and 6.5 years in <a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>. Most trials described a gender ratio ranging from 59% to 73% males. One study (<a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>) enrolled children with moderate to severe asthma symptoms at baseline, defined as requiring inhaled β<sub>2</sub>‐agonists at a minimum of every two hours, having forced expiratory volume in one second (FEV<sub>1</sub>) of 25% to 80% of predicted value or having a clinical asthma score of three to nine on a scale of zero to 10 (higher indicating worse). The other trials did not report asthma severity at baseline (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>), and no trials provided data that were stratified according to the severity of baseline airway obstruction. </p> </section> <section id="CD010283-sec-0059"> <h5 class="title">Intervention drugs</h5> <p>Important variability must be noted in the proportion of participants who had received anticholinergics before randomisation. Indeed, in <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>, children had received intensive ipratropium bromide before randomisation, with a mean of 5.9 doses in the control group and 6.0 doses in the treatment group, but in <a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>, only three of 210 participants (all in the treatment group) had received anticholinergics in the emergency department before randomisation. The number of participants who received anticholinergics before enrolment was not reported in the remaining three studies (<a href="./references#CD010283-bbs2-0003" title="LewDB , HerrodHG , CrawfordLV . Combination of atropine and isoetharine aerosol therapy in pediatric acute asthma. Annals of Allergy1990;64(2 Pt 2):195‐200. [] ">Lew 1990</a>; <a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>) </p> <p>The intervention drug and frequency (<a href="#CD010283-tbl-0002">Table 1</a>) were as follows: 250 μg ipratropium bromide every four hours, every six hours afterwards and then every eight hours, depending on the asthma care algorithm phase (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>); 250 μg ipratropium bromide every 30 to 60 minutes initially, progressing to every two hours and then to every four hours as the participant improved clinically (<a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>); 250 μg ipratropium bromide every eight hours (<a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>); or 250 μg ipratropium bromide given within set limits at the discretion of the nursing staff (<a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>). </p> <div class="table" id="CD010283-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Intensity of anticholinergic treatment</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Studies</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anticholinergic treatment</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250 μg of ipratropium bromide by jet nebulisation every 4 hours during phase I, every 6 hours during phase II and every 8 hours during phase III of the ACA </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nebulised ipratropium bromide inhalation solution 1.0 mL (250 μg) every half an hour to 1 hour at the beginning, progressing to 2 hours and then to 4 hours as the patient improves clinically </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010283-bbs2-0003" title="LewDB , HerrodHG , CrawfordLV . Combination of atropine and isoetharine aerosol therapy in pediatric acute asthma. Annals of Allergy1990;64(2 Pt 2):195‐200. [] ">Lew 1990</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An inhalation of 0.1% atropine sulfate (0.05 mg/kg up to 2 mg in total) at baseline or 4 hours later depending on randomisation </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nebulised ipratropium 250 μg 30 minutes after the first dose of salbutamol and every 8 hours afterwards </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nebuliser with 250 μg ipratropium bromide given within set limits at the discretion of the nursing staff </p> </td> </tr> </tbody> </table> </div> </section> <section id="CD010283-sec-0060"> <h5 class="title">Co‐intervention</h5> <p>The use of systemic corticosteroids was variable. All children in two trials received corticosteroids delivered intravenously or orally (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>). However, only 78% of participants in the control group and 74% of those in the treatment group were given oral corticosteroids in one study (<a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>), and fewer participants received systemic steroids (26% and 28% in control and treatment groups, respectively) in the remaining study (<a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>). Intravenous aminophylline was used as a rescue therapy in two older studies (<a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>). If the clinical condition of a child was deteriorating in <a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>, subcutaneous epinephrine (0.01 mg/kg, maximum 0.5 mg) was added as part of the rescue therapy. </p> </section> <section id="CD010283-sec-0061"> <h5 class="title">Outcomes</h5> <p>The primary efficacy outcome, that is, duration of hospital stay, was documented in three trials (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>; <a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>) in a total of 327 children. None of these trials reported the primary safety outcome for our review, that is, serious adverse events. Other reported outcomes included admission to the ICU, need for supplemental asthma therapy, time to short‐acting β<sub>2</sub>‐agonists spaced at four hours or longer, relapse within 72 hours of discharge from the hospital and change from baseline in asthma severity measured as lung function, symptoms or clinical scores, adverse health effects and withdrawals. </p> </section> </section> <section id="CD010283-sec-0062"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD010283-sec-0107" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD010283-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>Full details of risk of bias for all seven eligible trials are listed in the <a href="./references#CD010283-sec-0106" title="">Characteristics of included studies</a> table, and a graphical summary is presented in <a href="#CD010283-fig-0002">Figure 2</a>. However, the following information pertains only to the four trials contributing data to the review. </p> <div class="figure" id="CD010283-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010283-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>All four trials reported the method of randomisation in sufficient detail to confirm adequacy. </p> <section id="CD010283-sec-0064"> <h4 class="title">Allocation</h4> <p>Two of four trials contributing data reported details on allocation concealment, and both convincingly reported a valid allocation concealment (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>). Therefore, we judged these two trials to be at low risk of bias and the remaining trials to be at unclear risk of bias (<a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>). </p> </section> <section id="CD010283-sec-0065"> <h4 class="title">Blinding</h4> <p>All trials reported double‐blinding, with convincing details indicating low risk of bias. </p> </section> <section id="CD010283-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>All four trials contributing data (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>; <a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>) reported on missing data; the proportion of withdrawals or missing values was balanced in numbers across intervention groups with similar reasons for missing data across groups, or no missing data were noted at all; thus all four trials were considered at low risk of bias on this criterion. </p> </section> <section id="CD010283-sec-0067"> <h4 class="title">Selective reporting</h4> <p>Two trials (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>) clearly specified primary and secondary outcomes and reported all outcomes and thus were considered at low risk of bias on this criterion. </p> </section> <section id="CD010283-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>We encountered no other significant sources of bias in the included trials contributing data to the review. </p> </section> </section> <section id="CD010283-sec-0069"> <h3 class="title" id="CD010283-sec-0069">Effects of interventions</h3> <p>See: <a href="./full#CD010283-tbl-0001"><b>Summary of findings for the main comparison</b> Combination of anticholinergics + beta<sub>2</sub>‐agonists versus beta<sub>2</sub>‐agonists alone</a> </p> <section id="CD010283-sec-0070"> <h4 class="title">Primary efficacy outcome: duration of hospital stay</h4> <p>Three trials (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>; <a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>) representing 327 children hospitalised with acute asthma contributed to the primary endpoint, that is, duration of hospital stay. The difference in hours of length of hospitalisation between participants treated with the combination of anticholinergics and short‐acting β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone was not statistically significant, with an MD of ‐0.28 hours (95% CI ‐5.07 to 4.52; <a href="./references#CD010283-fig-0004" title="">Analysis 1.1</a>; <a href="#CD010283-fig-0003">Figure 3</a>) and no apparent heterogeneity (I<sup>2</sup> = 0%). Because of the similarity of trials contributing to the primary outcome with regards to the age of enrolled children, the absence of any trial conducted in the ICU, the use of similar doses of anticholinergics and co‐intervention with systemic corticosteroids in all participants in two trials (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>) and three‐quarters of participants in the remaining trial (<a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>), we could not perform any of the a priori planned subgroup analyses on the primary efficacy outcome. </p> <div class="figure" id="CD010283-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot: Combination of anticholinergics + β2‐agonists versus β2‐agonists alone, outcome: duration of the hospital stay (hours)." data-id="CD010283-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot: Combination of anticholinergics + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, outcome: duration of the hospital stay (hours). </p> </div> </div> </div> <p>As all trials contributing data on the primary outcome were of high methodological quality and were published as full text, we did not perform sensitivity analyses on quality and publication status. </p> </section> <section id="CD010283-sec-0071"> <h4 class="title">Primary safety outcome: serious adverse events</h4> <p>No trials reported information on serious adverse events.</p> </section> <section id="CD010283-sec-0072"> <h4 class="title">Secondary outcomes</h4> <section id="CD010283-sec-0073"> <h5 class="title">Duration of stay in ICU</h5> <p>No studies reported on this outcome.</p> </section> <section id="CD010283-sec-0074"> <h5 class="title">Admission to the ICU</h5> <p>No admission to the ICU was described by the one study reporting on this outcome (<a href="./references#CD010283-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD010283-sec-0075"> <h5 class="title">Ventilation assistance</h5> </section> <section id="CD010283-sec-0076"> <h5 class="title">No studies reported on this outcome.</h5> </section> <section id="CD010283-sec-0077"> <h5 class="title">Need for supplemental asthma therapy</h5> <p>Four trials (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>; <a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>) representing 465 children contributed data on this outcome. No statistically significant impact of therapy on the need for supplemental therapy was described (RR 0.77, 95% CI 0.41 to 1.42; <a href="./references#CD010283-fig-0006" title="">Analysis 1.3</a>). The supplemental asthma therapy was intravenous aminophylline in two studies (<a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>), intravenous aminophylline or oral theophylline in one study (<a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>) and an "intensification regimen," consisting of subcutaneous epinephrine (0.01 mg/kg, maximum 0.5 mg) and a one‐time 500‐μg dose of ipratropium bromide nebulised in combination with higher‐dose albuterol (5.0 mg) in another study (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>). </p> </section> <section id="CD010283-sec-0078"> <h5 class="title">Time to short‐acting β<sub>2</sub>‐agonists spaced at four hours or longer </h5> <p>Two trials (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>) representing 290 participants contributed to this outcome. No statistically significant group difference (MD ‐2.17, 95% CI ‐7.01 to 2.66; <a href="./references#CD010283-fig-0007" title="">Analysis 1.4</a>) was reported. </p> </section> <section id="CD010283-sec-0079"> <h5 class="title">Change from baseline in asthma severity measured as lung function, symptoms or clinical scores </h5> <p>Two trials reported on the change from baseline in the asthma clinical score eight to 36 hours after initial treatment (higher is worse). No statistically significant group difference was described (SMD 0.02, 95% CI ‐0.34 to 0.38; <a href="./references#CD010283-fig-0008" title="">Analysis 1.5</a>). </p> <p>Only a single trial reported on peak expiratory flow rate (PEFR) and described no statistically significant group difference in any of these outcomes (<a href="./references#CD010283-fig-0010" title="">Analysis 1.7</a>). No pooling of data was thus possible. </p> </section> <section id="CD010283-sec-0080"> <h5 class="title">Relapse</h5> <p>No relapse was reported in the one study reporting on these outcomes (<a href="./references#CD010283-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD010283-sec-0081"> <h5 class="title">Adverse health effects</h5> <p>Two trials (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>) totaling 290 children reported that no adverse health events were observed (<a href="./references#CD010283-fig-0011" title="">Analysis 1.8</a>). </p> </section> <section id="CD010283-sec-0082"> <h5 class="title">Withdrawals</h5> <p>Two trials (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>) representing 294 children contributed to this outcome. No statistically significant group difference was noted in overall withdrawals (RR 0.80, 95% CI 0.38 to 1.70; <a href="./references#CD010283-fig-0012" title="">Analysis 1.9</a>) or in the proportion of withdrawals due to deterioration reported by a single trial (<a href="./references#CD010283-fig-0013" title="">Analysis 1.10</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010283-sec-0083" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010283-sec-0083"></div> <section id="CD010283-sec-0084"> <h3 class="title" id="CD010283-sec-0084">Summary of main results</h3> <p>In children hospitalised on hospital wards for an acute asthma exacerbation, the combination of nebulised anticholinergics with short‐acting β<sub>2</sub>‐agonists was associated with no statistically significant reduction in duration of hospital stay. We did not set <i>a priori</i> boundary for equivalence, but after reviewing the literature to determine the cut‐off for a clinically meaningful reduction in length of hospital stay, we proposed that a group difference of 8 hours be considered the minimally clinically important based on various reported length of hospital stay (<a href="./references#CD010283-bbs2-0131" title="CunninghamS , LoganC , LockerbieL , DunnMJG , McMurryA , PrescottRJ . Effect of an Integrated Care Pathway on Acute Asthma/Wheezein Children Attending Hospital: Cluster Randomized Trial. J Pediatr2008;152:315‐20. ">Cunningham 2008</a>; <a href="./references#CD010283-bbs2-0149" title="SmithM , IqbalSMSI , RoweBH , N’DiayeT . Corticosteroids for hospitalised children with acute asthma. Cochrane Database of Systematic Reviews2003, Issue 110.1002/14651858.CD002886.. [DOI: 10.1002/14651858.CD002886] ">Smith 2003</a>; <a href="./references#CD010283-bbs2-0138" title="LimTK , ChinNK , LeeKH , StebbingsAM . Early discharge of patients hospitalizedwith acute asthma: a controlled study. RESPIRATORY MEDICINE2000;94:1234‐1240. ">Lim 2000</a>). Indeed, the narrow confidence intervals rule out an effect of eight hours or larger of combination therapy over β<sub>2</sub>‐agonists alone. Because of the similarity of trial designs and participant characteristics (supported by the absence of significant heterogeneity) and incomplete reporting, it was not possible to explore whether characteristics of participants or therapy, such as age, admission site (ward or ICU) or intensity of anticholinergic treatment or co‐interventions, could influence the magnitude of response attributable to the addition of anticholinergics. All trials contributing to the primary outcome were of high methodological quality and were published in full text, thus no bias due to quality or publication status was apparent. Although power was severely limited by the small number of trials, precluding the use of any statistics (<a href="./references#CD010283-bbs2-0135" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated September 2011]. The Cochrane Collaboration. www.cochrane‐handbook.org, 2011. ">Higgins 2011</a>), inspection of the funnel plot did not suggest bias. </p> <p>This finding was supported by all secondary outcomes, which showed no statistically significant group differences in the need for supplemental asthma therapy, asthma clinical scores, time to short‐acting β<sub>2</sub>‐agonists spaced at four hours or longer and withdrawals. Although the remaining outcomes could not be pooled because they were reported in only one trial, none showed a statistically significant group difference or effect. </p> <p>Our findings contrast with those of a prior systematic review of RCTs, which concluded on the efficacy of multiple doses of inhaled anticholinergics in combination with β<sub>2</sub>‐agonist therapy versus β<sub>2</sub>‐agonist alone in the emergency management of severe asthma exacerbations (<a href="./references#CD010283-bbs2-0142" title="PlotnickL , DucharmeF . Combined inhaled anticholinergics and beta2‐agonists for initial treatment of acute asthma in children. Cochrane Database of Systematic Reviews2000, Issue 3. [DOI: 10.1002/14651858.CD000060] ">Plotnick 2000</a>) and, more recently, on the treatment of children with moderate and severe exacerbations (<a href="./references#CD010283-bbs2-0133" title="GriffithsB , DucharmeFM . Combined inhaled anticholinergics and short‐acting beta2‐agonists for initial treatment of acute asthma in children. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD000060.pub2] ">Griffiths 2013</a>). Recognising that the onset of action of oral corticosteroids is within three to four hours (<a href="./references#CD010283-bbs2-0145" title="RoweBH , SpoonerC , DucharmeF , BretzlaffJ , BotaG . Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database of Systematic Reviews2001, Issue 1. [DOI: 10.1002/14651858.CD002178] ">Rowe 2001</a>), we hypothesise that the beneficial effect of anticholinergics is best observed before the onset of action of systemic corticosteroids, at which point the effect of the latter surpasses that of the former. As hospital admission typically occurs at least three to four hours after oral corticosteroids are administered in the emergency department, perhaps the relative beneficial effect of anticholinergics becomes negligible when compared with systemic corticosteroids. </p> <p>Only two trials (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>) examined adverse health effects; in both trials, no adverse health effects were observed in either intervention group. In the absence of adverse events in 145 intervention participants in these two trials, the upper limit around this null estimate is 2%. No trial reported any serious adverse health event—our primary safety outcome—possibly because of the absence of events, although we cannot rule out sub‐optimal documentation or reporting. The paucity of data prevents any firm conclusions on the safety of either treatment strategy based on the proportion of adverse health effects or withdrawals, but the proportions would appear to be low. However, use of anticholinergics in the emergency department was not associated with an increase in serious adverse events or adverse events (<a href="./references#CD010283-bbs2-0133" title="GriffithsB , DucharmeFM . Combined inhaled anticholinergics and short‐acting beta2‐agonists for initial treatment of acute asthma in children. Cochrane Database of Systematic Reviews2013, Issue 8. [DOI: 10.1002/14651858.CD000060.pub2] ">Griffiths 2013</a>; <a href="./references#CD010283-bbs2-0142" title="PlotnickL , DucharmeF . Combined inhaled anticholinergics and beta2‐agonists for initial treatment of acute asthma in children. Cochrane Database of Systematic Reviews2000, Issue 3. [DOI: 10.1002/14651858.CD000060] ">Plotnick 2000</a>). </p> </section> <section id="CD010283-sec-0085"> <h3 class="title" id="CD010283-sec-0085">Overall completeness and applicability of evidence</h3> <p>The results of this review apply to children one to 18 years old, with a good representation of preschoolers and school‐aged children, as three studies (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>) included children with a mean or median age younger than five years and one trial (<a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>) included predominantly school‐aged children. Concomitant use of aminophylline and withholding of systemic corticosteroids in participants with acute asthma was noted in two older studies (<a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a>; <a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a>); these approaches contrast to the current standard practice in which systemic corticosteroids was used systematically in all enrolled participants in the two recent studies (<a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a>; <a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a>). Of note, one cannot extrapolate these data to children with impending respiratory failure admitted to the ICU, as the trial was conducted in the ICU. </p> </section> <section id="CD010283-sec-0086"> <h3 class="title" id="CD010283-sec-0086">Quality of the evidence</h3> <p>A very modest number of studies contributed data to the review. Trials contributing most of the data were of high methodological quality. Yet the four studies contributing data totaled only 472 children hospitalised for acute asthma. Clearly the large confidence intervals observed for all outcomes suggest that additional trials could change the conclusion. In addition, the paucity of trials prevented identification of subgroups (e.g. age, intensity of treatment, admission site) for whom the treatment may provide more or less effect. Finally, evidence regarding the safety profile of nebulised anticholinergics is insufficient. </p> </section> <section id="CD010283-sec-0087"> <h3 class="title" id="CD010283-sec-0087">Potential biases in the review process</h3> <p>No evidence of bias due to publication or methodological quality was shown by funnel plot. We recognise that, in view of the small number of studies, our power to identify bias was limited. </p> </section> <section id="CD010283-sec-0088"> <h3 class="title" id="CD010283-sec-0088">Agreements and disagreements with other studies or reviews</h3> <p>On the basis of efficacy, available results support the recommendation of current national and international guidelines (<a href="./references#CD010283-bbs2-0132" title="Global Initiative forAsthma . From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf (accessed 8 January 2014). ">GINA 2014</a>; <a href="./references#CD010283-bbs2-0140" title="National Asthma education and Prevention Program. NAEPP Expert Panel Report Guidelines for the Diagnosis and Management of Asthma. http://www.nhlbi.nih.gov/guidelines/asthma/ (accessed 8 January 2014). ">NAEPP 2011</a>) that anticholinergics should not be used in children hospitalised for an acute asthma exacerbation beyond initial treatment in the emergency department. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010283-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010283-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010283-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot: Combination of anticholinergics + β2‐agonists versus β2‐agonists alone, outcome: duration of the hospital stay (hours)." data-id="CD010283-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot: Combination of anticholinergics + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, outcome: duration of the hospital stay (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone, Outcome 1 Duration of hospital stay (hours)." data-id="CD010283-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Combination of anticholinergics (AC) + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, Outcome 1 Duration of hospital stay (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#CD010283-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone, Outcome 2 Admission to the intensive care unit." data-id="CD010283-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Combination of anticholinergics (AC) + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, Outcome 2 Admission to the intensive care unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#CD010283-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone, Outcome 3 Need for supplemental asthma therapy." data-id="CD010283-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Combination of anticholinergics (AC) + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, Outcome 3 Need for supplemental asthma therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#CD010283-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone, Outcome 4 Time to short‐acting β2‐agonists spaced at 4 hours or longer (hours)." data-id="CD010283-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Combination of anticholinergics (AC) + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, Outcome 4 Time to short‐acting β<sub>2</sub>‐agonists spaced at 4 hours or longer (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#CD010283-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone, Outcome 5 Asthma clinical scores 8 to 36 hours after initial treatment." data-id="CD010283-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Combination of anticholinergics (AC) + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, Outcome 5 Asthma clinical scores 8 to 36 hours after initial treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#CD010283-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone, Outcome 6 Relapse within 72 hours of discharge from hospital." data-id="CD010283-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Combination of anticholinergics (AC) + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, Outcome 6 Relapse within 72 hours of discharge from hospital. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#CD010283-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone, Outcome 7 Percentages of predicted PEFR at 8 to 36 hours after initial treatment." data-id="CD010283-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Combination of anticholinergics (AC) + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, Outcome 7 Percentages of predicted PEFR at 8 to 36 hours after initial treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#CD010283-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone, Outcome 8 Adverse health effects." data-id="CD010283-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Combination of anticholinergics (AC) + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, Outcome 8 Adverse health effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#CD010283-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone, Outcome 9 Overall withdrawals." data-id="CD010283-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Combination of anticholinergics (AC) + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, Outcome 9 Overall withdrawals. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#CD010283-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010283-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/urn:x-wiley:14651858:media:CD010283:CD010283-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_t/tCD010283-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone, Outcome 10 Withdrawals due to deterioration." data-id="CD010283-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Combination of anticholinergics (AC) + β<sub>2</sub>‐agonists versus β<sub>2</sub>‐agonists alone, Outcome 10 Withdrawals due to deterioration. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#CD010283-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/media/CDSR/CD010283/image_n/nCD010283-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010283-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Combination of anticholinergics + beta2‐agonists versus beta2‐agonists alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Combination of AC + beta<sub>2</sub>‐agonists versus beta<sub>2</sub>‐agonists alone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: children hospitalised with an acute asthma exacerbation</b> <br/> <b>Settings:</b> hospitalised<br/> <b>Intervention:</b> combination of anticholinergic + beta<sub>2</sub>‐agonists<br/> <b>Comparison:</b> beta<sub>2</sub>‐agonists alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Beta<sub>2</sub>‐agonistsalone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Combination of AC + beta<sub>2</sub>‐agonists</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of the hospital stay (hours)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of the hospital stay (hours) in the control groups was<br/> 44 hours </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in duration of hospital stay (hours) was 0.28 hours in the intervention groups </p> <p>Mean 43.8 (39 to 49) hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐0.28 hours</b> <br/> (‐5.07 to 4.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>327<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to regular dose of short‐acting beta<sub>2</sub>‐agonists (hours)<sup>2</sup> </b> </p> <p><b>Follow‐up: 4 hours or longer</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to regular short‐acting beta<sub>2</sub>‐agonists in the control groups was 33 hours </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in time to regular short‐acting beta<sub>2</sub>‐agonists in the intervention groups was 2.17 hours </p> <p>Mean 31 (26 to 36) hours</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>‐2.17 hours</b> <br/> (‐7.01 to 2.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>269<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asthma clinical scores</b> </p> <p><b>Follow‐up: 8 to 36 hours after initial treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.02 SMD</b> (‐0.34 to 0.38) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>117<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Scores were measured on different scales.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Admission to the intensive care unit</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>210<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single trial reported admission to the intensive care unit. No events were reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall withdrawals</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 100</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 100</b> <br/> (4 to 15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.59</b> <br/> (0.27 to 1.30) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>294<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse health events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>290<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adverse events were reported in either trial</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the mean control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded because of wide confidence intervals. </p> <p><sup>2</sup>This is the time at which emergency dosing with the trial intervention was replaced with regular 4‐hourly treatment with short‐acting beta<sub>2</sub>‐agonists. </p> <p><sup>3</sup>No events were reported in either arm of the studies. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Combination of anticholinergics + beta2‐agonists versus beta2‐agonists alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010283-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Intensity of anticholinergic treatment</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Studies</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Anticholinergic treatment</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010283-bbs2-0001" title="CravenD , KercsmarCM , MyersTR , O'RiordanMA , GolonkaG , MooreS , et al. Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. Journal of Pediatrics2001;138(1):51‐8. [] ">Craven 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>250 μg of ipratropium bromide by jet nebulisation every 4 hours during phase I, every 6 hours during phase II and every 8 hours during phase III of the ACA </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010283-bbs2-0002" title="GogginN , MacarthurC , ParkinPC . Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Archives of Pediatrics and Adolescent Medicine2001;155(12):1329‐34. ">Goggin 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nebulised ipratropium bromide inhalation solution 1.0 mL (250 μg) every half an hour to 1 hour at the beginning, progressing to 2 hours and then to 4 hours as the patient improves clinically </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010283-bbs2-0003" title="LewDB , HerrodHG , CrawfordLV . Combination of atropine and isoetharine aerosol therapy in pediatric acute asthma. Annals of Allergy1990;64(2 Pt 2):195‐200. [] ">Lew 1990</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>An inhalation of 0.1% atropine sulfate (0.05 mg/kg up to 2 mg in total) at baseline or 4 hours later depending on randomisation </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010283-bbs2-0006" title="RaynerRJ , CartlidgePH , UptonCJ . Salbutamol and ipratropium in acute asthma. Archives of Disease in Childhood1987;62(8):840‐1. [] ">Rayner 1987</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nebulised ipratropium 250 μg 30 minutes after the first dose of salbutamol and every 8 hours afterwards </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD010283-bbs2-0007" title="StorrJ , LenneyW . Nebulised ipratropium and salbutamol in asthma. Archives of Disease in Childhood1986;61(6):602‐3. [] ">Storr 1986</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nebuliser with 250 μg ipratropium bromide given within set limits at the discretion of the nursing staff </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Intensity of anticholinergic treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/full#CD010283-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010283-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of hospital stay (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐5.07, 4.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Admission to the intensive care unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Need for supplemental asthma therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.41, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Time to short‐acting β<sub>2</sub>‐agonists spaced at 4 hours or longer (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.17 [‐7.01, 2.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Asthma clinical scores 8 to 36 hours after initial treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.34, 0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Relapse within 72 hours of discharge from hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Percentages of predicted PEFR at 8 to 36 hours after initial treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Adverse health effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Overall withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.27, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Withdrawals due to deterioration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Combination of anticholinergics (AC) + β2‐agonists versus β2‐agonists alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010283.pub2/references#CD010283-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010283.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010283-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010283-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010283-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010283-note-0002">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010283\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010283\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010283\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010283\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010283\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=cdmLYOAV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010283.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010283.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010283.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010283.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010283.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724425112"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010283.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724425116"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010283.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e62827a48f3fd',t:'MTc0MDcyNDQyNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 